Advertisement
Letters
JAMA. 2006;295(24):2848-2849. doi: 10.1001/jama.295.24.2848-c

Academic Medical Centers and Conflicts of Interest—Reply

  1. Troyen A. Brennan, MD
  1. Aetna Inc
    Hartford, Conn
  1. David J. Rothman, PhD;
  2. Susan Chimonas, PhD
  1. Columbia University College of Physicians and Surgeons
    New York, NY
  1. James Naughton, MD
  1. University of California
    San Francisco
  1. Jordan Cohen, MD;
  2. Linda Blank
  1. Association of American Medical Colleges
    Washington, DC
  1. Harry Kimball, MD
  1. University of Washington School of Medicine
    Seattle
  1. David Blumenthal, MD
  1. Harvard Medical School
    Boston, Mass
  1. Neil Smelser, PhD
  1. University of California
    Berkeley
  1. Jerome P. Kassirer, MD
  1. Tufts-New England Medical Center
    Boston, Mass
  1. JanLori Goldman
  1. Health Privacy Project
    Washington, DC

Since this article does not have an abstract, we have provided the first 150 words of the full text.

In Reply: The authors of these letters help put our recommendations into a larger framework. Dr Meador, Dr Gozum, Drs Goldblum and Franzblau, and Dr Ting identify some of the other avenues for industry influence over medical practice in addition to those issues we discussed, including advertising in medical journals, funds for GME, and marketing to practitioners outside of AMCs. Dr Poses and colleagues point to managed care as a prolific source of conflict of interest. We agree that all of these activities challenge the principles of medical professionalism.

We were aware of these many dimensions of conflict of interest in clinical practice, both in AMCs and in the community, although we did not address all of them specifically. Rather, we chose to focus more narrowly on physicians and pharmaceutical and device manufacturers because we believe that not only is this set of conflicts particularly prevalent but that this is …

Related articles

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals